Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance
Author:
Publisher
Public Library of Science (PLoS)
Subject
General Medicine
Reference39 articles.
1. Challenges in tuberculosis drug research and development;AM Ginsberg;Nat Med,2007
2. Advances in clinical trial design for development of new TB treatments: A call for innovation;C Lienhardt;PLoS Med,2019
3. Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape;PPJ Phillips;PLoS Med,2019
4. Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs;G Davies;PLoS Med,2019
5. Target regimen profiles for treatment of tuberculosis: a WHO document;C Lienhardt;Eur Respir J,2017
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Towards comprehensive clinical trials for new tuberculosis drug regimens: policy recommendations from a stakeholder analysis;BMJ Global Health;2024-04
2. Complementary supramolecular drug associates in perfecting the multidrug therapy against multidrug resistant bacteria;Frontiers in Immunology;2024-02-13
3. Treatment of drug-susceptible and drug-resistant tuberculosis;The Challenge of Tuberculosis in the 21st Century;2023-09-01
4. Cocrystallizing and Codelivering Complementary Drugs to Multidrugresistant Tuberculosis Bacteria in Perfecting Multidrug Therapy;Current Topics in Medicinal Chemistry;2023-07
5. Clinical Trials of TB: Challenges and Opportunities;Respiratory Disease Series: Diagnostic Tools and Disease Managements;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3